Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+amlodipiin+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+5mg+12,5mg 98tk; 40mg+5mg+12,5mg 30tk; 40mg+5mg+12,5mg 28tk; 40mg+5mg+12,5mg 90tk; 40mg+5mg+12,5mg 84tk; 40mg+5mg+12,5mg 56tk; 40mg+5mg+12,5mg 300tk; 40mg+5mg+12,5mg 280tk; 40mg+5mg+12,5mg 14tk

Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+amlodipiin+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+5mg+25mg 10tk; 40mg+5mg+25mg 280tk; 40mg+5mg+25mg 300tk; 40mg+5mg+25mg 7tk; 40mg+5mg+25mg 84tk; 40mg+5mg+25mg 500tk; 40mg+5mg+25mg 28tk; 40mg+5mg+25mg 90tk; 40mg+5mg+25mg 14tk; 40mg+5mg+25mg 30tk

Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+amlodipiin+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+10mg+25mg 10tk; 40mg+10mg+25mg 14tk; 40mg+10mg+25mg 30tk; 40mg+10mg+25mg 56tk; 40mg+10mg+25mg 280tk; 40mg+10mg+25mg 84tk; 40mg+10mg+25mg 28tk; 40mg+10mg+25mg 90tk; 40mg+10mg+25mg 500tk

Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+amlodipiin+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+10mg+12,5mg 50tk; 40mg+10mg+12,5mg 98tk; 40mg+10mg+12,5mg 14tk; 40mg+10mg+12,5mg 28tk; 40mg+10mg+12,5mg 7tk; 40mg+10mg+12,5mg 10tk; 40mg+10mg+12,5mg 500tk; 40mg+10mg+12,5mg 90tk; 40mg+10mg+12,5mg 300tk; 40mg+10mg+12,5mg 280tk; 40mg+10mg+12,5mg 56tk; 40mg+10mg+12,5mg 84tk; 40mg+10mg+12,5mg 30tk

Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+amlodipiin+hüdroklorotiasiid - õhukese polümeerikattega tablett - 20mg+5mg+12,5mg 50tk; 20mg+5mg+12,5mg 280tk; 20mg+5mg+12,5mg 14tk; 20mg+5mg+12,5mg 7tk; 20mg+5mg+12,5mg 98tk; 20mg+5mg+12,5mg 56tk; 20mg+5mg+12,5mg 300tk; 20mg+5mg+12,5mg 500tk; 20mg+5mg+12,5mg 28tk; 20mg+5mg+12,5mg 90tk; 20mg+5mg+12,5mg 84tk

Estonya - Estonca - Ravimiamet

statens serum institut - tuberkuloosi tekitaja, elus, nõrgestatud - süstesuspensiooni pulber ja lahusti - 0,75mg 10tk

Avrupa Birliği - Estonca - EMA (European Medicines Agency)

ucb pharma s.a.   - bimekizumab - psoriaas - immunosupressandid - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - deferasiroks - õhukese polümeerikattega tablett - 360mg 300tk; 360mg 90tk; 360mg 30tk

Estonya - Estonca - Ravimiamet

alembic pharmaceuticals europe limited - deferasiroks - õhukese polümeerikattega tablett - 90mg 90tk; 90mg 30tk; 90mg 300tk

Estonya - Estonca - Ravimiamet

aj vaccines a/s - tuberkuloosi tekitaja, elus, nõrgestatud - süstesuspensiooni pulber ja lahusti - 0,75mg 10tk